METS-IR指数与非心脏手术后心肌损伤的关系:基于CKM综合征分期的队列研究

Association between METS-IR index and myocardial injury after noncardiac surgery: A cohort study based on CKM syndrome staging

  • 摘要:
    背景 非心脏手术后心肌损伤(myocardial injury after noncardiac surgery,MINS)是术后常见的心血管并发症。代谢评分-胰岛素抵抗指数(metabolic score for insulin resistance,METS-IR)作为新型胰岛素抵抗指标,其与MINS的关系及在心血管-肾脏-代谢(cardiovascular-kidney-metabolic,CKM)综合征分期中的关联性尚不明确。
    目的 探讨术前METS-IR在不同CKM综合征分期中与MINS的相关性。
    方法 回顾性纳入2020年1月至2022年12月在解放军总医院第一医学中心接受非心脏手术的患者。以MINS为主要结局,术后急性肾损伤(acute kidney injury,AKI)为次要结局。先采用限制性立方样条(restricted cubic spline,RCS)分析METS-IR与结局的剂量-反应关系,再采用多因素logistic回归分析METS-IR与结局指标的关联关系。按CKM分期进行分层分析,分别在Stage 0 ~ 1期、Stage 2期、Stage 3 ~ 4期亚组中拟合logistic回归模型。采用E值评估残余未测量混杂的影响。
    结果 共纳入12 086例患者,平均年龄(61.5 ± 9.5)岁,男5 269例(43.6%)。MINS发生率为7.1%(853/12 086),AKI发生率为8.4%(1 010/12 086)。RCS分析表明METS-IR与MINS呈线性正相关(非线性检验P=0.205,整体P<0.001)。Logistic回归结果表明,METS-IR每升高1个标准差,MINS风险升高(OR=1.19,95% CI:1.07 ~ 1.32,P=0.002),AKI风险同样升高(OR=1.14,95% CI:1.02 ~ 1.28,P=0.021)。按CKM分期分层分析显示,METS-IR与MINS的正相关在各分期中均独立存在:Stage 0 ~ 1期OR=1.30(95% CI:1.11 ~ 1.51,P=0.001),Stage 2期OR=1.21(95% CI:1.06 ~ 1.38,P=0.004),Stage 3 ~ 4期OR=1.16(95% CI:1.03 ~ 1.31,P=0.013)。E值为1.67,提示需要中等强度的未测量混杂方能完全解释当前关联。
    结论 非心脏手术患者术前METS-IR与MINS及AKI风险呈独立关联,在不同CKM分期患者中METS-IR均可作为围术期心肾风险评估的参考指标。

     

    Abstract:
    Background Myocardial injury after noncardiac surgery (MINS) is a common postoperative cardiovascular complication. While the metabolic score for insulin resistance (METS-IR) serves as a novel marker for insulin resistance, its relationship with MINS and its relevance to cardiovascular-kidney-metabolic (CKM) syndrome staging are not yet established.
    Objective To investigate the association between preoperative METS-IR and MINS across different CKM syndrome stages.
    Methods Patients who underwent noncardiac surgery at the First Medical Center of PLA General Hospital from January 2020 to December 2022 were retrospectively included. The primary outcome was MINS and the secondary outcome was acute kidney injury (AKI). Restricted cubic spline (RCS) analysis was used to assess the dose-response relationships between METS-IR and the outcomes, and multivariable logistic regression was used to analyze the associations of METS-IR with the outcomes. Stratified analyses by CKM stage were performed, with separate logistic regression models fitted in the Stage 0-1, Stage 2, and Stage 3-4 subgroups. The E-value was used to assess the influence of residual unmeasured confounders.
    Results A total of 12 086 patients were included, with a mean age of 61.5 ± 9.5 years and 5 269 (43.6%) were male. The incidence of MINS was 7.1% (853/12 086) and that of AKI was 8.4% (1 010/12 086). RCS analysis showed a linear positive association between METS-IR and MINS (P for nonlinearity=0.205; overall P < 0.001). Logistic regression showed that for each 1-SD increase in METS-IR, the risk of MINS increased (OR=1.19, 95% CI: 1.07 - 1.32, P=0.002), as did the risk of AKI (OR=1.14, 95% CI: 1.02-1.28, P=0.021). Stratified analysis by CKM stage showed that the positive association between METS-IR and MINS was independent in each stage: Stage 0-1 (OR=1.30, 95% CI: 1.11 - 1.51, P=0.001), Stage 2 (OR=1.21, 95% CI: 1.06 - 1.38, P=0.004), and Stage 3-4 (OR=1.16, 95% CI: 1.03 - 1.31, P=0.013). The E-value was 1.67 (1.34 for the CI bound), indicating that moderate-strength unmeasured confounder would be required to fully explain the observed association.
    Conclusion In patients undergoing noncardiac surgery, preoperative METS-IR is independently associated with the risks of MINS and AKI. Among different CKM syndrome stages, METS-IR may serve as a reference indicator for perioperative cardiorenal risk assessment.

     

/

返回文章
返回